Guloy, Casan M.

HRN: 08-55-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CEFTAZIDIME 1GM (VIAL)
05/29/2025
06/04/2025
IV
1g
Q8h
Cap-Mr
Waiting Final Action 
05/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/30/2025
06/06/2025
IV
4.5g
Q8
Complicated UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: